Track the 셀트리온헬스케어 share price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 셀트리온헬스케어 has recorded 49 insider filings. The latest transaction was disclosed on 27 December 2023 (Purchase). Among the most active insiders: 셀트리온홀딩스. The full history is openly available.
49
Insider Decl.
n/a
Thresholds
n/a
24 ops.
Buy Volume
n/a
3 ops.
Sell Volume
2Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Celltrion Healthcare is a South Korean company focused on the development and commercialization of biosimilar drugs. It is listed on the Korea Exchange (XKRX).